Aclaris Therapeutics to Participate in the William Blair Biotech Focus Conference 2021
July 08 2021 - 7:00AM
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage
biopharmaceutical company focused on developing novel drug
candidates for immuno-inflammatory diseases, today announced that
Dr. Neal Walker, President and CEO of Aclaris, will participate in
a virtual panel discussion at the William Blair Biotech Focus
Conference 2021 titled “Novel Targets for Autoimmune Diseases,” on
Thursday, July 15, 2021 at 11:00 a.m. ET. Management will be
available July 15th throughout the day for virtual one-on-one
meetings.
A live webcast of the panel discussion may be accessed through
the “Events” page of the “Investors” section of Aclaris’ website,
www.aclaristx.com. The webcast will be archived for at least 30
days on the Aclaris website.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical
company developing a pipeline of novel drug candidates to address
the needs of patients with immuno-inflammatory diseases who lack
satisfactory treatment options. The company has a multi-stage
portfolio of drug candidates powered by a robust R&D engine
exploring protein kinase regulation. For additional information,
please visit www.aclaristx.com.
Aclaris Contact
investors@aclaristx.com
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Sep 2023 to Sep 2024